313 related articles for article (PubMed ID: 29312131)
1. Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies.
La Morgia C; Di Vito L; Carelli V; Carbonelli M
Front Neurol; 2017; 8():710. PubMed ID: 29312131
[TBL] [Abstract][Full Text] [Related]
2. Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond.
La Morgia C; Ross-Cisneros FN; Sadun AA; Carelli V
Front Neurol; 2017; 8():162. PubMed ID: 28522986
[TBL] [Abstract][Full Text] [Related]
3. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurol; 2017; 8():701. PubMed ID: 29312125
[TBL] [Abstract][Full Text] [Related]
4. Optic neuropathies: the tip of the neurodegeneration iceberg.
Carelli V; La Morgia C; Ross-Cisneros FN; Sadun AA
Hum Mol Genet; 2017 Oct; 26(R2):R139-R150. PubMed ID: 28977448
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.
Cunha JP; Moura-Coelho N; Proença RP; Dias-Santos A; Ferreira J; Louro C; Castanheira-Dinis A
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2079-2092. PubMed ID: 27377656
[TBL] [Abstract][Full Text] [Related]
6. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy.
Asanad S; Tian JJ; Frousiakis S; Jiang JP; Kogachi K; Felix CM; Fatemeh D; Irvine AG; Ter-Zakarian A; Falavarjani KG; Barboni P; Karanjia R; Sadun AA
Curr Eye Res; 2019 Jun; 44(6):638-644. PubMed ID: 30649972
[No Abstract] [Full Text] [Related]
7. Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Gupta S; Zivadinov R; Ramanathan M; Weinstock-Guttman B
Expert Rev Neurother; 2016 Jul; 16(7):765-75. PubMed ID: 27138997
[TBL] [Abstract][Full Text] [Related]
8. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.
Chrysou A; Jansonius NM; van Laar T
Parkinsonism Relat Disord; 2019 Jul; 64():40-49. PubMed ID: 31054866
[TBL] [Abstract][Full Text] [Related]
9. The role of Optical Coherence Tomography in optic neuropathies.
Iorga RE; Moraru A; Ozturk MR; Costin D
Rom J Ophthalmol; 2018; 62(1):3-14. PubMed ID: 29796429
[TBL] [Abstract][Full Text] [Related]
10. Optical Coherence Tomography Angiography in Neurodegenerative Disorders.
Pellegrini M; Vagge A; Ferro Desideri LF; Bernabei F; Triolo G; Mastropasqua R; Del Noce CD; Borrelli E; Sacconi R; Iovino C; Di Zazzo AD; Forlini M; Giannaccare G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32498362
[TBL] [Abstract][Full Text] [Related]
11. The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Normando EM; Davis BM; De Groef L; Nizari S; Turner LA; Ravindran N; Pahlitzsch M; Brenton J; Malaguarnera G; Guo L; Somavarapu S; Cordeiro MF
Acta Neuropathol Commun; 2016 Aug; 4(1):86. PubMed ID: 27535749
[TBL] [Abstract][Full Text] [Related]
12. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
13. Detection of macular ganglion cell loss in preperimetric glaucoma patients with localized retinal nerve fibre defects by spectral-domain optical coherence tomography.
Na JH; Lee K; Lee JR; Baek S; Yoo SJ; Kook MS
Clin Exp Ophthalmol; 2013 Dec; 41(9):870-80. PubMed ID: 23777476
[TBL] [Abstract][Full Text] [Related]
14. Subtype-specific response of retinal ganglion cells to optic nerve crush.
Daniel S; Clark AF; McDowell CM
Cell Death Discov; 2018; 4():7. PubMed ID: 30062056
[TBL] [Abstract][Full Text] [Related]
15. [Optical Coherence Tomography in Disorders of the Central Nervous System].
Papadopoulou A; Oertel FC; Zimmermann H; Zeitz O; Brandt AU; Paul F
Klin Monbl Augenheilkd; 2018 Nov; 235(11):1242-1258. PubMed ID: 30458564
[TBL] [Abstract][Full Text] [Related]
16. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
[TBL] [Abstract][Full Text] [Related]
17. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
[TBL] [Abstract][Full Text] [Related]
18. Psychophysical testing in rodent models of glaucomatous optic neuropathy.
Grillo SL; Koulen P
Exp Eye Res; 2015 Dec; 141():154-63. PubMed ID: 26144667
[TBL] [Abstract][Full Text] [Related]
19. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.
Cheung CY; Ong YT; Hilal S; Ikram MK; Low S; Ong YL; Venketasubramanian N; Yap P; Seow D; Chen CL; Wong TY
J Alzheimers Dis; 2015; 45(1):45-56. PubMed ID: 25428254
[TBL] [Abstract][Full Text] [Related]
20. Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells.
Schmitt HM; Schlamp CL; Nickells RW
Neurosci Lett; 2016 Jun; 625():11-5. PubMed ID: 26733303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
